191 filings
Page 9 of 10
8-K
gt9vb7bxcoe87e
18 Oct 19
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:13pm
8-K
evi79 qsi
3 Oct 19
Termination of a Material Definitive Agreement
6:30am
8-K
4egvdrq
9 Sep 19
Regulation FD Disclosure
7:00am
8-K
ljnteb22 s5k
14 Aug 19
Results of Operations and Financial Condition
12:00am
8-K
a13ebdf
5 Aug 19
Departure of Directors or Certain Officers
5:16pm
8-K
uzi ea7ooe0
15 May 19
AgeX Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update
4:25pm
10-Q
p2ap1 q524bggcrpd
15 May 19
Quarterly report
12:00am
10-K/A
90iauh36de
30 Apr 19
Annual report (amended)
4:34pm
10-K
0cnp3i pprlxh6mw
1 Apr 19
Annual report
5:21pm
8-K
ddkdrxotuse 9xi5
1 Apr 19
AgeX Therapeutics Reports Fourth Quarter and Annual 2018 Financial Results and Provides Business Update
5:02pm
8-K
3yn7 kdj0
27 Mar 19
Entry into a Material Definitive Agreement
4:56pm
D
beoiv whbh0hupd
22 Mar 19
$5M in equity / securities to be acquired, sold $4.5M, 17 investors
4:19pm
8-K
fho5qp5x phsc6zdk
22 Mar 19
Unregistered Sales of Equity Securities
7:00am
8-K
ib0hyq
15 Mar 19
Departure of Directors or Certain Officers
4:15pm
8-K
9nij1q0ujgu
7 Mar 19
Entry into a Material Definitive Agreement
6:15am
S-8
q7869j2qghdkun0247
30 Jan 19
Registration of securities for employees
5:01pm
8-K
k53mlh3egco 29p
29 Nov 18
AgeX Therapeutics, Inc. Shares Commence Trading on the NYSE American
7:00am
CT ORDER
zkoc2bygpfi8wa bb274
28 Nov 18
Confidential treatment order
11:12am
SEC STAFF ACTION
q7eac23awsq0sq7h7r1
27 Nov 18
SEC staff action: Order
5:09pm